Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
"Strong Buy. Company changing news due Q1.
I did my research on Avacta (AVCT), Novacyte (NCYT), Omega Diagnostics (ODX), genedrive (GDR).
1 - Genedrive - 26.54 - 1.06M - the Best opportunity - No orders - waiting for approval - still low - multibagger
2 - Omega - 212.26 - 8.51M I already have a position. - No orders - waiting for approval
3 Avacta - 376.45 - 3.20M - Price Too high & MC too high - No orders - waiting for approval
4 Novacyt - 794.78 - TBC - Too high for me
Https://www.pharmiweb.com/press-release/2021-01-21/covid-19-testing-sector-demand-set-to-continue-amid-vaccine-rollout"
Other countries recognising the need for easy to conduct, quick turn-around tests deploying saliva based tests...
https://cnnphilippines.com/news/2021/1/26/red-cross-saliva-test-in-strategic-areas-ramp-up-testing.html
Can only see more countries adopting similar approach as it is a fundamental requirement for containing this pandemic.
Earlier GDR article for ref:
https://www.proactiveinvestors.co.uk/companies/news/932119/genedrive-plc-unveils-15-minute-covid-19-point-of-care-test-direct-from-saliva-932119.html
Testing 59p now.
58.56 +9.56 +19.51%
Volume: 2,572,060
Well done all for buying and holding.
This will be like NCYT - we will be £3-5+ on news
Genedrive #GDR Investor Webinar
https://www.youtube.com/watch?v=HCiOLYEcWJ4
https://www.youtube.com/watch?v=jN4sZ9bWYto
Just look at the below links. buy-in before the news lands anytime now.
In light of the increasing numbers of COVID-19 cases throughout the US and the need to expand capacity for COVID-19 testing during the public health emergency, the FDA has stated that it does not object to a commercial manufacturer's development and distribution of SARS-CoV-2 test kits for specimen testing for a reasonable period of time, where the test has been validated and while the manufacturer has made an Emergency Use Authorization request, where the manufacturer gives appropriate notification of validation to FDA, and where the manufacturer provides instructions for use of the test and posts data about the test's performance characteristics on the manufacturer's website.
https://twitter.com/snooptrades/status/1354332450726551554?s=19
https://www.sysmex-europe.com/n/products/diagnostics/sars-cov-2.html
These idiots (Lloyd & his Cronies) told investors not to invest at 40p.
Ignore them.... this is a fantastic opportunity to buy
https://www.sysmex-europe.com/n/products/diagnostics/sars-cov-2.html
Wow Wow
WOW ... 57.50 +17.35%
Volume: 2,389,172 Bid/Ask: 57.00 / 58.00
We are in the international market including Japan.
Fantastic news
Check this out on Twitter.
https://twitter.com/snooptrades/status/1354332450726551554?s=19
We have broken the 57p resistance
Volume: 2,292,061 Bid/Ask: 57.50 / 58.00
President Biden announcement yesterday is a game-changer for GDR
President Joe Biden seeks to reset the nation’s inconsistent coronavirus testing efforts with a $50 billion plan and more federal oversight.
Biden’s plan calls for a newly created Pandemic Testing Board to coordinate a “clear, unified approach” to testing for COVID-19, a marked difference from the Trump administration’s policy of states establishing their own plans with federal support.
https://eu.usatoday.com/story/news/health/2021/01/24/bidens-covid-testing-push-calls-more-supplies-and-rapid-tests/4215619001/
"Strong Buy. Company changing news due Q1.
I did my research on Avacta (AVCT), Novacyte (NCYT), Omega Diagnostics (ODX), genedrive (GDR).
1 - Genedrive - 26.54 - 1.06M - the Best opportunity - No orders - waiting for approval - still low - multibagger
2 - Omega - 212.26 - 8.51M I already have a position. - No orders - waiting for approval
3 Avacta - 376.45 - 3.20M - Price Too high & MC too high - No orders - waiting for approval
4 Novacyt - 794.78 - TBC - Too high for me
Https://www.pharmiweb.com/press-release/2021-01-21/covid-19-testing-sector-demand-set-to-continue-amid-vaccine-rollout"
Other countries recognising the need for easy to conduct, quick turn-around tests deploying saliva based tests...
https://cnnphilippines.com/news/2021/1/26/red-cross-saliva-test-in-strategic-areas-ramp-up-testing.html
Can only see more countries adopting similar approach as it is a fundamental requirement for containing this pandemic.
Earlier GDR article for ref:
https://www.proactiveinvestors.co.uk/companies/news/932119/genedrive-plc-unveils-15-minute-covid-19-point-of-care-test-direct-from-saliva-932119.html
Out of the £20BN pile #GDR distributor (who only has ONE COVID test - Genedrive) has won a tender
https://twitter.com/snooptrades/status/1354332450726551554?s=19
Keep on watching until the news lands. this will be £5+ because low market cap.
wow, 57p now - going up fast. Crazy Volume: 1,925,974
Load up guys... this is ready to take off. we might be getting RNS anytime now.
Do not miss this golden opportunity.
Out of the £20BN pile #GDR distributor (who only has ONE COVID test - Genedrive) has won a tender
https://twitter.com/snooptrades/status/1354332450726551554?s=19
Load up guys... this is ready to take off. we might be getting RNS anytime now.
Do not miss this golden opportunity.
Out of the £20BN pile #GDR distributor (who only has ONE COVID test - Genedrive) has won a tender
https://twitter.com/snooptrades/status/1354332450726551554?s=19
Out of the £20BN pile #GDR distributor (who only has ONE COVID test - Genedrive) has won a tender
https://twitter.com/snooptrades/status/1354332450726551554?s=19
The price is rocketing 56.20.
Well done all.
people are still waiting on the sideline for £1+ to jump in.
Fantastic News - we should get an RNS soon.
Sysmex are one of our distributors:
https://www.genedrive.com/distribution/index.php
26-Jan-21 16:35:57 198.625 -750,000 Unknown* 195.00 200.00 -1m O
26-Jan-21 16:35:57 198.625 750,000 Buy* 195.00 200.00 1m O
26-Jan-21 16:34:07 195.00 750,000 Sell* 195.00 200.00 1m O
26-Jan-21 16:32:28 197.50 750,000 Unknown* 195.00 200.00 1m
I think some tree shaking going on here for cheap shares
Look on 19/01 someone bought £1M of shares.